-
16
fighting covid-19， hepalink in action
the covid-19 epidemic touches the heart of all chinese people. faced with the raging epidemic, hepalink, as a pharmaceutical enterprise, takes on its social responsibilities through practical actions. on february 2, 2020, the company launched emergence donations. the first enoxaparin sodium injections “prolongin”, specifically used for covid-19 patients, were delivere...
-
16
hepalink's enoxaparin sodium preparation allowed clinic...
although covid-19 has been effectively put under control in china, it is still rampant in the rest of the world. faced with this global major public health emergency, all countries are taking actions to strengthen epidemic prevention and develop anti-epidemic drugs and reagents. on april 14, 2020, la repubblica reported that aifa approved follow-up heparin resea...
-
16
in the first quarter of 2020, hepalink is to earn 250 to 300...
on march 30, shenzhen hepalink pharmaceutical co., ltd (hereinafter referred to as “hepalink”, 002399.sz) released the performance estimation of the first quarter of 2020. according to the estimation, the net profit that goes to the shareholders of the listed company in the first quarter of 2020 is expected to reach 250 to 300 million rmb. an analysis of t...
-
06
hepalink announces the appointment of healthcare senior exec...
shenzhen, china--(business wire)—shenzhen hepalink pharmaceutical group co., ltd. (szse: 002399), a china-based global pharmaceutical company targeting high-mortality diseases with significant unmet medical needs, announced the appointment of mr. frank sun as executive director and the election of mr. sun as the vice chairman of the board. mr. sun will work with the board on...